A cancer drug for certain types of leukemia and lymphoma can also prevent reactions to some of the most common airborne allergies, according to a recent Northwestern Medicine study.
Browsing: Clinical Breakthroughs
Northwestern scientists and clinicians are using wearable technology to gather a wealth of novel information about patients and to devise innovative ways to treat and prevent disease.
A new strategy combining five separate tests provided a significantly better risk assessment of cardiovascular disease among adults, compared to traditional measures, according to a study published in Circulation.
An investigational neural stem cell therapy that works with a common cold virus to seek out and attack malignant glioma is being tested at Northwestern Medicine in a phase I clinical trial.
Younger men with prostate cancer had a decreased risk of cancer progression while under active surveillance, compared to men older than 60, according to a recent study.
Systolic blood pressure for African-American patients dropped between one to five points when they moved to less segregated neighborhoods, according to a new study.
The first drug using spherical nucleic acids to be systemically given to humans has been developed by Northwestern University scientists and approved by the Food and Drug Administration as an investigational new drug for an early-stage clinical trial in the deadly brain cancer glioblastoma multiforme.
Veterans Affairs hospitals outperformed civilian hospitals on most measures of quality and patient safety, but scored lower on indicators of patient experience, according to new Northwestern Medicine research.
Hans Breiter, ’88 MD, professor of Psychiatry and Behavioral Sciences, is leading the development of a radical, proactive approach to stopping violence using advanced mathematical models of human emotion.